---
title: "NeOnc Technologies Holdings, Inc. (NTHI.US)"
type: "quote"
locale: "en"
url: "https://longbridge.com/en/quote/NTHI.US.md"
symbol: "NTHI.US"
name: "NeOnc Technologies Holdings, Inc."
industry: "制藥"
---

# NeOnc Technologies Holdings, Inc. (NTHI.US)

| Item | Detail |
|------|--------|
| Industry | 制藥 |
| Location | 美股市場 |
| Website | [www.neonc.com](https://www.neonc.com) |

## Company Profile

NeOnc Technologies Holdings, Inc.是一家臨床階段的生物制藥公司，專注于開發顱內惡性腫瘤的治療方法。其主要產品候選藥物包括 NEO100，這是一種純化的前百里香酸形式，目前正在進行 IIa 期臨床試驗；以及 NEO212，這是一種共價結合的分子，將化療藥物替莫唑胺與百里香醇結合，目前正在進行 I/II 期臨床試驗，旨在口服治療原發性腦癌，如腦膜瘤、高級別膠質瘤、膠質母細胞瘤和繼發性腦癌。該公司之前被稱為 NAS-ONC, Inc.，並更名為 NeOnc Technologies Holdings, Inc

## Financial Score

> *Longbridge Financial Score™ — Proprietary multi-factor rating model by [Longbridge](https://longbridge.com). This score is independently calculated by Longbridge and is not affiliated with any third-party rating agency.*
> Updated: 2026-02-25T04:30:15.000Z

**Overall: D (0.73)**

**Industry**: Pharmaceuticals

| Metric | Value |
|--------|-------|
| Industry Ranking | 143 / 189 |
| Industry Median | C |
| Industry Average | C |

- **Style**: Value - Stocks where the company's main business is in a mature stage.
- **Scale**: Small - The company's operation has a high degree of growth and volatility, making it easy to achieve high investment returns.

### Score Analysis

**Style Score**: 

#### Growth Score: 

| Indicator | Value | Rating |
|-----------|-------|--------|
| Revenue YoY | -4.78% |  |
| Net Profit YoY | -209.32% |  |

#### Value Score: 

| Indicator | Value | Rating |
|-----------|-------|--------|
| P/B Ratio | -18.63 |  |
| Dividend Ratio | 0.00% |  |


**Size Score**: 

#### Market Cap Score: 

| Indicator | Value | Rating |
|-----------|-------|--------|
| Market Cap | 220.11M |  |

#### Revenue Score: 

| Indicator | Value | Rating |
|-----------|-------|--------|
| Revenue | 59990.00 |  |


**Multi Score**: D

#### Profit Score: B

| Indicator | Value | Rating |
|-----------|-------|--------|
| ROE | 572.25% | A |
| Profit Margin | -81472.06% | E |
| Gross Margin | 0.00% | E |

#### Growth Score: D

| Indicator | Value | Rating |
|-----------|-------|--------|
| Revenue YoY | -4.78% | D |
| Net Profit YoY | -209.32% | E |
| Total Assets YoY | 48.80% | A |
| Net Assets YoY | -124.29% | E |

#### Cash Score: D

| Indicator | Value | Rating |
|-----------|-------|--------|
| Cash Flow Margin | -0.12% | D |
| OCF YoY | -4.78% | D |

#### Operating Score: E

| Indicator | Value | Rating |
|-----------|-------|--------|
| Turnover | 0.02 | E |

#### Debt Score: E

| Indicator | Value | Rating |
|-----------|-------|--------|
| Gearing Ratio | 389.36% | E |


```chart-data:radar
{
  "title": "Longbridge Financial Score - NeOnc Technologies Holdings, Inc.",
  "chart_type": "radar",
  "dimensions": [
    {
      "name": "Profit",
      "grade": "B",
      "indicators": [
        {
          "name": "ROE",
          "value": "572.25%",
          "rating": "A"
        },
        {
          "name": "Profit Margin",
          "value": "-81472.06%",
          "rating": "E"
        },
        {
          "name": "Gross Margin",
          "value": "0.00%",
          "rating": "E"
        }
      ]
    },
    {
      "name": "Growth",
      "grade": "D",
      "indicators": [
        {
          "name": "Revenue YoY",
          "value": "-4.78%",
          "rating": "D"
        },
        {
          "name": "Net Profit YoY",
          "value": "-209.32%",
          "rating": "E"
        },
        {
          "name": "Total Assets YoY",
          "value": "48.80%",
          "rating": "A"
        },
        {
          "name": "Net Assets YoY",
          "value": "-124.29%",
          "rating": "E"
        }
      ]
    },
    {
      "name": "Cash",
      "grade": "D",
      "indicators": [
        {
          "name": "Cash Flow Margin",
          "value": "-0.12%",
          "rating": "D"
        },
        {
          "name": "OCF YoY",
          "value": "-4.78%",
          "rating": "D"
        }
      ]
    },
    {
      "name": "Operating",
      "grade": "E",
      "indicators": [
        {
          "name": "Turnover",
          "value": "0.02",
          "rating": "E"
        }
      ]
    },
    {
      "name": "Security",
      "grade": "E",
      "indicators": [
        {
          "name": "Gearing Ratio",
          "value": "389.36%",
          "rating": "E"
        }
      ]
    }
  ]
}
```

### Peer Comparison

| Rank | Name | Profit | Growth | Operation | Security | Cash | Rating |
|------|------|--------|--------|-----------|----------|------|--------|
| 01 | 禮來 (US.LLY) | A | A | B | E | B | B |
| 02 | ROCHE HOLDINGS AG (US.RHHVF) | A | B | B | D | C | B |
| 03 | 羅氏(ADR) (US.RHHBY) | A | B | B | D | C | B |
| 04 | 阿斯利康 (US.AZN) | A | B | C | D | C | B |
| 05 | 諾華制藥 (US.NVS) | A | B | C | D | C | B |

## Valuation Analysis

| Metric | Current | Industry Ranking | High | Median | Low |
|--------|---------|-----------------|------|--------|-----|
| PE (TTM) | -4.50 | 153/257 | - | - | - |
| PB | -18.63 | 221/257 | - | - | - |
| PS (TTM) | 3669.18 | 156/257 | 3340.49 | 2542.20 | 1351.07 |
| Dividend Yield | 0.00% | - | - | - | - |

## References

- [Company Overview](https://longbridge.com/en/quote/NTHI.US/overview.md) - Shareholders, executives, business segments
- [Financials](https://longbridge.com/en/quote/NTHI.US/norm.md) - Income statement, balance sheet, cash flow, distribution plan
- [Topics & Discussions](https://longbridge.com/en/quote/NTHI.US/topics.md) - Community topics and discussions

---

> **Disclaimer**: This article is for reference only and does not constitute any investment advice.